Kevin Kim, MD

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Mirdametinib in Patients With Advanced NF1-mutant Melanoma	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, hereditary disease, hereditary neoplastic syndrome, inherited neurodegenerative disorder, melanocytic neoplasm, melanoma, metastatic melanoma, neoplasm, nerve sheath neoplasm, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, neuroendocrine neoplasm, neurofibroma, neurofibromatosis, primitive neuroectodermal tumor, skin disorder, skin neoplasm	Recruiting	Phase 2	2025-11-19		NCT07237100

Clinical trials